Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any thyroid cancer, nonmedullary in which the cause of the disease is a mutation in the HABP2 gene.
Features include: Non-medullary thyroid carcinoma.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Hormones | 1 | Non-medullary thyroid carcinoma |
Biomarker and diagnostic research for thyroid cancer, nonmedullary, 5 has been reported in the published literature.
No clinical trials have been registered for thyroid cancer, nonmedullary, 5.
274 publications have been identified in PubMed for thyroid cancer, nonmedullary, 5. Kisho has analyzed 143 by research type. Research spans Epidemiology / Natural History (24%), Basic Science / Preclinical (21%), and Clinical Trial Publication (19%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 35 | 24% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 2:14 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Laboratory research |
30 |
21% |
Clinical study results | 27 | 19% |
Testing and diagnosis research | 20 | 14% |
Research summaries | 18 | 13% |
Patient case studies | 8 | 6% |
New treatment approaches | 4 | 3% |
Other research | 1 | 1% |
Onuma AE (2026). [PMID: 41371824](https://pubmed.ncbi.nlm.nih.gov/41371824/). *Surgery*. [Other]
Hussain I (2026). [PMID: 41621643](https://pubmed.ncbi.nlm.nih.gov/41621643/). *Endocr Pract*. [Review / Meta-Analysis]
Ouyang H (2026). [PMID: 41519961](https://pubmed.ncbi.nlm.nih.gov/41519961/). *Sci Rep*. [Diagnostic / Biomarker]
Kalshetty V (2026). [PMID: 42209037](https://pubmed.ncbi.nlm.nih.gov/42209037/). *BMJ Case Rep*. [Case Report / Case Series]
Patrizio A (2026). [PMID: 41376649](https://pubmed.ncbi.nlm.nih.gov/41376649/). *J Endocr Soc*. [Clinical Trial Publication]
Gui S (2026). [PMID: 41565206](https://pubmed.ncbi.nlm.nih.gov/41565206/). *Mol Cell Proteomics*. [Clinical Trial Publication]
Li S (2026). [PMID: 41557763](https://pubmed.ncbi.nlm.nih.gov/41557763/). *Cancer Control*. [Review / Meta-Analysis]
Ashorobi D (2026). [PMID: 30969597](https://pubmed.ncbi.nlm.nih.gov/30969597/). *Unknown Journal*. [Review / Meta-Analysis]
Francis DO (2026). [PMID: 41733915](https://pubmed.ncbi.nlm.nih.gov/41733915/). *JAMA Netw Open*. [Epidemiology / Natural History]
Scholfield DW (2026). [PMID: 41411004](https://pubmed.ncbi.nlm.nih.gov/41411004/). *JAMA Otolaryngol Head Neck Surg*. [Clinical Trial Publication]
AI-curated news mentioning thyroid cancer, nonmedullary, 5
Updated Sep 10, 2026
Sapanisertib shows promise for treating rare mTOR-driven disorders, with potential applications in various cancers including bladder and ovarian cancer. Successful late-stage clinical development could unlock orphan-drug incentives and enhance adoption in specialized treatment centers.
A recent study indicates that incidentally detected papillary thyroid carcinoma does not negatively affect pregnancy outcomes during fertility treatment. This finding may influence clinical practices regarding the management of thyroid cancer in women seeking fertility assistance.
A nationwide database study investigates the prevalence and outcomes of metastases to the thyroid gland, providing valuable insights into this rare occurrence. The findings may inform clinical practices and patient management strategies.
The updated Dutch 2026 guidelines for pediatric differentiated thyroid carcinoma align with European standards, enhancing treatment protocols. This update reflects ongoing efforts to standardize care across regions for this rare cancer.